APC and laryngotracheoesophageal cleft: Concerning LC, significantly higher APC and RARβ2 promoter methylation levels were apparent in small-cell lung cancer (SCLC) patients compared to those with adenocarcinoma (p = 0.005 and p = 0.035, respectively) (Figure 2(C1,C2)).